David Donghyung Lee, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liver Transplantation | 45 | 2024 | 2325 | 6.200 |
Why?
|
Tissue and Organ Procurement | 18 | 2024 | 943 | 4.140 |
Why?
|
Carcinoma, Hepatocellular | 18 | 2023 | 2292 | 1.850 |
Why?
|
Tissue Donors | 16 | 2024 | 2311 | 1.780 |
Why?
|
End Stage Liver Disease | 12 | 2020 | 352 | 1.730 |
Why?
|
Liver Neoplasms | 18 | 2023 | 4313 | 1.470 |
Why?
|
Donor Selection | 11 | 2023 | 227 | 1.450 |
Why?
|
Graft Survival | 19 | 2024 | 3794 | 1.100 |
Why?
|
Perfusion | 4 | 2024 | 1374 | 1.010 |
Why?
|
Waiting Lists | 10 | 2020 | 762 | 1.000 |
Why?
|
Death | 6 | 2023 | 674 | 0.910 |
Why?
|
Organ Preservation | 3 | 2024 | 379 | 0.800 |
Why?
|
Neoplasm Recurrence, Local | 14 | 2023 | 9273 | 0.710 |
Why?
|
Florida | 6 | 2020 | 431 | 0.700 |
Why?
|
Cold Ischemia | 3 | 2018 | 67 | 0.680 |
Why?
|
Cholangiocarcinoma | 3 | 2020 | 550 | 0.640 |
Why?
|
Hepatic Artery | 3 | 2018 | 230 | 0.640 |
Why?
|
Liver Failure | 2 | 2019 | 249 | 0.630 |
Why?
|
Bile Duct Neoplasms | 2 | 2018 | 602 | 0.520 |
Why?
|
Kidney Transplantation | 4 | 2022 | 4217 | 0.510 |
Why?
|
Graft Rejection | 6 | 2019 | 4426 | 0.490 |
Why?
|
Constriction, Pathologic | 1 | 2018 | 1097 | 0.490 |
Why?
|
Primary Graft Dysfunction | 1 | 2016 | 111 | 0.480 |
Why?
|
Fatty Liver | 4 | 2023 | 777 | 0.450 |
Why?
|
Kaplan-Meier Estimate | 12 | 2020 | 6493 | 0.440 |
Why?
|
Warm Ischemia | 2 | 2024 | 58 | 0.440 |
Why?
|
Liver | 13 | 2023 | 7502 | 0.430 |
Why?
|
Ischemia | 3 | 2018 | 1863 | 0.420 |
Why?
|
Living Donors | 2 | 2021 | 638 | 0.400 |
Why?
|
Travel | 2 | 2015 | 785 | 0.400 |
Why?
|
Organ Transplantation | 1 | 2021 | 1150 | 0.380 |
Why?
|
Neoplasms, Complex and Mixed | 2 | 2020 | 35 | 0.340 |
Why?
|
Chemoembolization, Therapeutic | 2 | 2023 | 127 | 0.320 |
Why?
|
Gastric Fistula | 1 | 2009 | 73 | 0.310 |
Why?
|
Intestinal Fistula | 1 | 2009 | 143 | 0.300 |
Why?
|
Leucine | 1 | 2009 | 547 | 0.290 |
Why?
|
Colonic Diseases | 1 | 2009 | 200 | 0.290 |
Why?
|
Retrospective Studies | 24 | 2024 | 80170 | 0.280 |
Why?
|
Ablation Techniques | 2 | 2020 | 248 | 0.270 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3211 | 0.260 |
Why?
|
Risk Factors | 22 | 2023 | 73806 | 0.260 |
Why?
|
Patient Selection | 7 | 2019 | 4244 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 2 | 2018 | 3175 | 0.240 |
Why?
|
Hepatectomy | 2 | 2020 | 559 | 0.230 |
Why?
|
Treatment Outcome | 24 | 2023 | 64379 | 0.230 |
Why?
|
Middle Aged | 34 | 2024 | 219560 | 0.220 |
Why?
|
Tumor Burden | 5 | 2020 | 1893 | 0.220 |
Why?
|
International Normalized Ratio | 2 | 2016 | 382 | 0.220 |
Why?
|
Time Factors | 14 | 2020 | 39873 | 0.220 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2008 | 738 | 0.210 |
Why?
|
Biopsy | 4 | 2023 | 6768 | 0.200 |
Why?
|
Severity of Illness Index | 11 | 2020 | 15785 | 0.200 |
Why?
|
Hypoglycemia | 1 | 2009 | 881 | 0.190 |
Why?
|
Tissue and Organ Harvesting | 2 | 2017 | 373 | 0.190 |
Why?
|
Humans | 53 | 2024 | 758381 | 0.190 |
Why?
|
Reperfusion Injury | 2 | 2019 | 1022 | 0.190 |
Why?
|
Neoadjuvant Therapy | 4 | 2020 | 2821 | 0.190 |
Why?
|
Male | 36 | 2024 | 358742 | 0.180 |
Why?
|
San Francisco | 1 | 2020 | 162 | 0.180 |
Why?
|
Adult | 26 | 2024 | 219916 | 0.180 |
Why?
|
Female | 35 | 2024 | 390316 | 0.170 |
Why?
|
Aged | 24 | 2021 | 168217 | 0.170 |
Why?
|
Ontario | 1 | 2020 | 397 | 0.170 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 1599 | 0.160 |
Why?
|
Aspartate Aminotransferases | 2 | 2023 | 415 | 0.160 |
Why?
|
Bilirubin | 2 | 2023 | 437 | 0.160 |
Why?
|
Young Adult | 9 | 2019 | 58808 | 0.160 |
Why?
|
Kidney Failure, Chronic | 1 | 2011 | 2457 | 0.150 |
Why?
|
Alanine Transaminase | 2 | 2023 | 604 | 0.150 |
Why?
|
Survival Rate | 4 | 2021 | 12721 | 0.140 |
Why?
|
Virus Activation | 1 | 2019 | 319 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20500 | 0.140 |
Why?
|
Neoplasm Staging | 4 | 2020 | 11152 | 0.140 |
Why?
|
Preoperative Period | 1 | 2019 | 553 | 0.140 |
Why?
|
Risk Assessment | 10 | 2021 | 23883 | 0.130 |
Why?
|
Biliary Tract Diseases | 1 | 2017 | 157 | 0.130 |
Why?
|
Clinical Enzyme Tests | 1 | 2016 | 115 | 0.130 |
Why?
|
Multivariate Analysis | 4 | 2017 | 12096 | 0.120 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15225 | 0.120 |
Why?
|
California | 1 | 2019 | 1419 | 0.120 |
Why?
|
Cholangiography | 1 | 2014 | 181 | 0.120 |
Why?
|
Cold Temperature | 1 | 2018 | 780 | 0.120 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2012 | 3432 | 0.120 |
Why?
|
Adolescent | 8 | 2018 | 87888 | 0.110 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 36285 | 0.110 |
Why?
|
Program Evaluation | 2 | 2014 | 2490 | 0.110 |
Why?
|
Postoperative Complications | 5 | 2019 | 15638 | 0.110 |
Why?
|
Proportional Hazards Models | 6 | 2017 | 12440 | 0.110 |
Why?
|
Yttrium Radioisotopes | 1 | 2014 | 107 | 0.110 |
Why?
|
Renal Insufficiency | 1 | 2019 | 809 | 0.110 |
Why?
|
Liver Failure, Acute | 1 | 2015 | 181 | 0.110 |
Why?
|
Prognosis | 4 | 2024 | 29558 | 0.110 |
Why?
|
Cell Transplantation | 1 | 2015 | 472 | 0.110 |
Why?
|
Histocompatibility | 1 | 2014 | 316 | 0.100 |
Why?
|
United States | 13 | 2024 | 72140 | 0.100 |
Why?
|
Aged, 80 and over | 5 | 2018 | 58681 | 0.100 |
Why?
|
Niacinamide | 1 | 2014 | 414 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2010 | 1111 | 0.100 |
Why?
|
Hepacivirus | 1 | 2019 | 1333 | 0.100 |
Why?
|
Databases, Factual | 6 | 2019 | 7980 | 0.100 |
Why?
|
Hepatocytes | 2 | 2017 | 1230 | 0.100 |
Why?
|
Hepatitis C | 2 | 2019 | 1579 | 0.100 |
Why?
|
Follow-Up Studies | 7 | 2020 | 39060 | 0.090 |
Why?
|
Drug Hypersensitivity | 1 | 2020 | 915 | 0.090 |
Why?
|
Phenylurea Compounds | 1 | 2014 | 529 | 0.090 |
Why?
|
Length of Stay | 2 | 2016 | 6439 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1263 | 0.090 |
Why?
|
Michigan | 1 | 2011 | 341 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3617 | 0.090 |
Why?
|
Disease Progression | 4 | 2020 | 13468 | 0.090 |
Why?
|
Bone Marrow Cells | 1 | 2017 | 2414 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3425 | 0.080 |
Why?
|
Mesenchymal Stem Cells | 2 | 2017 | 1634 | 0.080 |
Why?
|
Hospitals, University | 1 | 2011 | 567 | 0.080 |
Why?
|
Reoperation | 1 | 2019 | 4282 | 0.080 |
Why?
|
Vena Cava, Inferior | 1 | 2012 | 458 | 0.080 |
Why?
|
Disease-Free Survival | 4 | 2020 | 6821 | 0.070 |
Why?
|
Liver Diseases | 1 | 2015 | 1296 | 0.070 |
Why?
|
Transplantation, Heterologous | 1 | 2015 | 2378 | 0.070 |
Why?
|
Liver Function Tests | 2 | 2019 | 523 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2019 | 3056 | 0.070 |
Why?
|
Propensity Score | 3 | 2019 | 1907 | 0.070 |
Why?
|
Necrosis | 2 | 2023 | 1604 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2016 | 1996 | 0.070 |
Why?
|
Blood Glucose | 3 | 2010 | 6347 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2023 | 8946 | 0.060 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1797 | 0.060 |
Why?
|
Fluoroscopy | 1 | 2009 | 944 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2634 | 0.060 |
Why?
|
Survival Analysis | 4 | 2020 | 10112 | 0.060 |
Why?
|
Incidental Findings | 1 | 2009 | 694 | 0.060 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1345 | 0.050 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2020 | 1791 | 0.050 |
Why?
|
Thrombosis | 1 | 2016 | 2929 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3362 | 0.050 |
Why?
|
Child | 4 | 2016 | 79813 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2014 | 2740 | 0.050 |
Why?
|
Organ Size | 2 | 2016 | 2252 | 0.050 |
Why?
|
Regeneration | 1 | 2010 | 1505 | 0.050 |
Why?
|
Heart Diseases | 1 | 2014 | 2782 | 0.050 |
Why?
|
Child, Preschool | 2 | 2016 | 42058 | 0.050 |
Why?
|
Prospective Studies | 4 | 2018 | 54136 | 0.040 |
Why?
|
Spleen | 1 | 2006 | 2296 | 0.040 |
Why?
|
Quality Improvement | 1 | 2016 | 3806 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2014 | 3732 | 0.040 |
Why?
|
Age Factors | 4 | 2018 | 18357 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2009 | 1155 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4158 | 0.040 |
Why?
|
Arizona | 1 | 2019 | 107 | 0.040 |
Why?
|
Insulin-Secreting Cells | 1 | 2006 | 896 | 0.040 |
Why?
|
Minnesota | 1 | 2019 | 338 | 0.040 |
Why?
|
beta-Lactams | 1 | 2020 | 157 | 0.040 |
Why?
|
Heart Transplantation | 1 | 2012 | 3220 | 0.040 |
Why?
|
United States Public Health Service | 1 | 2018 | 31 | 0.040 |
Why?
|
Reperfusion | 1 | 2019 | 270 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5629 | 0.040 |
Why?
|
Ataxia | 1 | 2000 | 305 | 0.040 |
Why?
|
Epilepsy, Generalized | 1 | 2000 | 178 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 262 | 0.040 |
Why?
|
Incidence | 1 | 2016 | 21273 | 0.040 |
Why?
|
Chemokine CXCL1 | 1 | 2017 | 105 | 0.040 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2017 | 103 | 0.040 |
Why?
|
Transaminases | 1 | 2017 | 196 | 0.030 |
Why?
|
alpha-Fetoproteins | 1 | 2017 | 222 | 0.030 |
Why?
|
Calcium Channels | 1 | 2000 | 618 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2017 | 414 | 0.030 |
Why?
|
Hepatitis B Antibodies | 1 | 2016 | 157 | 0.030 |
Why?
|
Rats, Nude | 1 | 2015 | 105 | 0.030 |
Why?
|
Glucose Tolerance Test | 2 | 2010 | 1172 | 0.030 |
Why?
|
Patient Dropouts | 1 | 2017 | 412 | 0.030 |
Why?
|
Caspase 3 | 1 | 2017 | 728 | 0.030 |
Why?
|
Portal Vein | 1 | 2017 | 429 | 0.030 |
Why?
|
Chronic Disease | 1 | 2009 | 9266 | 0.030 |
Why?
|
Brain Death | 1 | 2016 | 356 | 0.030 |
Why?
|
Albumins | 1 | 2015 | 575 | 0.030 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2017 | 498 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2011 | 26182 | 0.020 |
Why?
|
Streptozocin | 1 | 2010 | 193 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 22006 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2129 | 0.020 |
Why?
|
Animals | 6 | 2017 | 167777 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2016 | 1404 | 0.020 |
Why?
|
Software | 1 | 2023 | 4416 | 0.020 |
Why?
|
Infant | 1 | 2011 | 36054 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2017 | 3208 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5781 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2016 | 1786 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2017 | 2872 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8426 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3100 | 0.020 |
Why?
|
Kinetics | 2 | 2006 | 6371 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2014 | 3527 | 0.020 |
Why?
|
Oxygen | 1 | 2017 | 4192 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8530 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2016 | 2618 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9599 | 0.020 |
Why?
|
Decision Making | 1 | 2018 | 3915 | 0.010 |
Why?
|
Rats | 2 | 2015 | 23681 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8176 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7403 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22031 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9468 | 0.010 |
Why?
|
Mice | 3 | 2017 | 81107 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7377 | 0.010 |
Why?
|
Myoclonic Epilepsy, Juvenile | 1 | 2000 | 13 | 0.010 |
Why?
|
Codon, Terminator | 1 | 2000 | 125 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18942 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4919 | 0.010 |
Why?
|
Electric Conductivity | 1 | 2000 | 405 | 0.010 |
Why?
|
Body Mass Index | 1 | 2016 | 12876 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20052 | 0.010 |
Why?
|
Penetrance | 1 | 2000 | 388 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10719 | 0.010 |
Why?
|
Introns | 1 | 2000 | 978 | 0.010 |
Why?
|
Xenopus laevis | 1 | 2000 | 965 | 0.010 |
Why?
|
Mutation | 1 | 2000 | 29915 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 13286 | 0.010 |
Why?
|
Oocytes | 1 | 2000 | 1165 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 13959 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41252 | 0.010 |
Why?
|
Exons | 1 | 2000 | 2387 | 0.010 |
Why?
|
Gene Frequency | 1 | 2000 | 3612 | 0.010 |
Why?
|
Hypertension | 1 | 2012 | 8503 | 0.010 |
Why?
|
Pedigree | 1 | 2000 | 4578 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2006 | 11471 | 0.010 |
Why?
|
Base Sequence | 1 | 2000 | 12436 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 2000 | 13447 | 0.000 |
Why?
|
Genetic Variation | 1 | 2000 | 6548 | 0.000 |
Why?
|